Stuart Hwang

Stuart is a seasoned biotech executive and venture partner with over 25 years of experience translating research into clinical therapies for cancer, immunology, and rare diseases. A PhD graduate from UC Berkeley, he has a strong track record in company creation, drug development, and corporate strategy, from start-ups to large pharma.

Outside of his direct professional roles, Stuart shows a keen interest in the broader healthcare landscape. He follows and comments on the efficiency of healthcare providers and the impact of federal health policies on patient outcomes, indicating a passion for improving the overall system for American patients.

Unique fact: He co-founded Vincerx Pharma, where he in-licensed its oncology pipeline from a major pharmaceutical company and successfully took the company public on the Nasdaq.